Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine metabolic process (GO:0006558) | 5.17338563 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.17338563 |
3 | L-phenylalanine catabolic process (GO:0006559) | 5.10261352 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.10261352 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 4.76384944 |
6 | protein neddylation (GO:0045116) | 4.75801187 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.47180243 |
8 | tryptophan catabolic process (GO:0006569) | 4.47130074 |
9 | indole-containing compound catabolic process (GO:0042436) | 4.47130074 |
10 | indolalkylamine catabolic process (GO:0046218) | 4.47130074 |
11 | glycine metabolic process (GO:0006544) | 4.46126708 |
12 | glyoxylate metabolic process (GO:0046487) | 4.30689034 |
13 | kynurenine metabolic process (GO:0070189) | 4.24115190 |
14 | tryptophan metabolic process (GO:0006568) | 4.23505484 |
15 | serine family amino acid biosynthetic process (GO:0009070) | 4.19977452 |
16 | cysteine metabolic process (GO:0006534) | 4.17991275 |
17 | urea metabolic process (GO:0019627) | 4.13823128 |
18 | urea cycle (GO:0000050) | 4.13823128 |
19 | bile acid biosynthetic process (GO:0006699) | 4.02136581 |
20 | sulfur amino acid catabolic process (GO:0000098) | 4.01495768 |
21 | proteasome assembly (GO:0043248) | 3.99419871 |
22 | serine family amino acid catabolic process (GO:0009071) | 3.96011173 |
23 | serine family amino acid metabolic process (GO:0009069) | 3.91621556 |
24 | nitrogen cycle metabolic process (GO:0071941) | 3.82573328 |
25 | respiratory chain complex IV assembly (GO:0008535) | 3.81576801 |
26 | alpha-linolenic acid metabolic process (GO:0036109) | 3.78206187 |
27 | aldehyde catabolic process (GO:0046185) | 3.75018688 |
28 | high-density lipoprotein particle remodeling (GO:0034375) | 3.73434365 |
29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.69238268 |
30 | negative regulation of fibrinolysis (GO:0051918) | 3.68404202 |
31 | homocysteine metabolic process (GO:0050667) | 3.65131100 |
32 | aromatic amino acid family metabolic process (GO:0009072) | 3.58302905 |
33 | lysine metabolic process (GO:0006553) | 3.51790218 |
34 | lysine catabolic process (GO:0006554) | 3.51790218 |
35 | imidazole-containing compound metabolic process (GO:0052803) | 3.48106937 |
36 | amino-acid betaine metabolic process (GO:0006577) | 3.46362063 |
37 | regulation of fibrinolysis (GO:0051917) | 3.45055255 |
38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44103462 |
39 | protein carboxylation (GO:0018214) | 3.44103462 |
40 | bile acid metabolic process (GO:0008206) | 3.43030676 |
41 | regulation of protein activation cascade (GO:2000257) | 3.41284768 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 3.39913683 |
43 | L-serine metabolic process (GO:0006563) | 3.38740763 |
44 | glutathione derivative metabolic process (GO:1901685) | 3.36485390 |
45 | glutathione derivative biosynthetic process (GO:1901687) | 3.36485390 |
46 | complement activation, alternative pathway (GO:0006957) | 3.35851701 |
47 | negative regulation of cholesterol transport (GO:0032375) | 3.34601085 |
48 | negative regulation of sterol transport (GO:0032372) | 3.34601085 |
49 | regulation of cholesterol esterification (GO:0010872) | 3.31126218 |
50 | protein-lipid complex remodeling (GO:0034368) | 3.28459119 |
51 | macromolecular complex remodeling (GO:0034367) | 3.28459119 |
52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.28459119 |
53 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.28300241 |
54 | alpha-amino acid catabolic process (GO:1901606) | 3.28158209 |
55 | cellular glucuronidation (GO:0052695) | 3.26222774 |
56 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.26216508 |
57 | response to nitrosative stress (GO:0051409) | 3.24882971 |
58 | tetrahydrofolate metabolic process (GO:0046653) | 3.23871719 |
59 | ethanol oxidation (GO:0006069) | 3.20823051 |
60 | reverse cholesterol transport (GO:0043691) | 3.20334525 |
61 | phospholipid efflux (GO:0033700) | 3.19237553 |
62 | regulation of complement activation (GO:0030449) | 3.17764955 |
63 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.16236645 |
64 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.16152494 |
65 | amine catabolic process (GO:0009310) | 3.12194529 |
66 | cellular biogenic amine catabolic process (GO:0042402) | 3.12194529 |
67 | folic acid metabolic process (GO:0046655) | 3.12135120 |
68 | tyrosine metabolic process (GO:0006570) | 3.11351877 |
69 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.10387066 |
70 | indolalkylamine metabolic process (GO:0006586) | 3.09675839 |
71 | nucleoside salvage (GO:0043174) | 3.09566587 |
72 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.08766185 |
73 | bile acid and bile salt transport (GO:0015721) | 3.06585098 |
74 | acylglycerol homeostasis (GO:0055090) | 3.05068172 |
75 | triglyceride homeostasis (GO:0070328) | 3.05068172 |
76 | plasma lipoprotein particle clearance (GO:0034381) | 3.03579947 |
77 | cellular amino acid catabolic process (GO:0009063) | 3.02280177 |
78 | benzene-containing compound metabolic process (GO:0042537) | 3.01470330 |
79 | one-carbon metabolic process (GO:0006730) | 3.00864595 |
80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.00625593 |
81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.00625593 |
82 | plasma lipoprotein particle assembly (GO:0034377) | 3.00437449 |
83 | regulation of metalloenzyme activity (GO:0048552) | 2.96731534 |
84 | tricarboxylic acid cycle (GO:0006099) | 2.95945798 |
85 | keratinocyte development (GO:0003334) | 2.95778529 |
86 | cytochrome complex assembly (GO:0017004) | 2.95683777 |
87 | ribosomal small subunit assembly (GO:0000028) | 2.94537062 |
88 | uronic acid metabolic process (GO:0006063) | 2.94429204 |
89 | glucuronate metabolic process (GO:0019585) | 2.94429204 |
90 | NAD biosynthetic process (GO:0009435) | 2.92956617 |
91 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.91158306 |
92 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.90980614 |
93 | urate metabolic process (GO:0046415) | 2.90743316 |
94 | drug catabolic process (GO:0042737) | 2.89751622 |
95 | cellular ketone body metabolic process (GO:0046950) | 2.88726327 |
96 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.87777533 |
97 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.87777533 |
98 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.87649984 |
99 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.87649984 |
100 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.86918651 |
101 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.86167712 |
102 | cellular modified amino acid catabolic process (GO:0042219) | 2.85406920 |
103 | blood coagulation, intrinsic pathway (GO:0007597) | 2.84223630 |
104 | folic acid-containing compound metabolic process (GO:0006760) | 2.83313274 |
105 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.83172922 |
106 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.83130724 |
107 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.81353746 |
108 | cullin deneddylation (GO:0010388) | 2.80174624 |
109 | thrombin receptor signaling pathway (GO:0070493) | 2.78884279 |
110 | low-density lipoprotein particle remodeling (GO:0034374) | 2.78782757 |
111 | protein heterotetramerization (GO:0051290) | 2.78271659 |
112 | drug transmembrane transport (GO:0006855) | 2.75044346 |
113 | protein maturation by protein folding (GO:0022417) | 2.74884913 |
114 | primary alcohol catabolic process (GO:0034310) | 2.74641051 |
115 | cholesterol homeostasis (GO:0042632) | 2.74490083 |
116 | ether lipid metabolic process (GO:0046485) | 2.74171686 |
117 | L-ascorbic acid metabolic process (GO:0019852) | 2.72806802 |
118 | cholesterol efflux (GO:0033344) | 2.72555844 |
119 | arginine metabolic process (GO:0006525) | 2.72474381 |
120 | xenobiotic catabolic process (GO:0042178) | 2.70941992 |
121 | valine metabolic process (GO:0006573) | 2.70536458 |
122 | flavonoid metabolic process (GO:0009812) | 2.69262561 |
123 | pteridine-containing compound metabolic process (GO:0042558) | 2.69005301 |
124 | sterol homeostasis (GO:0055092) | 2.68877993 |
125 | carboxylic acid catabolic process (GO:0046395) | 2.68447190 |
126 | organic acid catabolic process (GO:0016054) | 2.68447190 |
127 | drug transport (GO:0015893) | 2.67169832 |
128 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.66716479 |
129 | adenosine metabolic process (GO:0046085) | 2.65094500 |
130 | phospholipid homeostasis (GO:0055091) | 2.64400998 |
131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.62920984 |
132 | platelet dense granule organization (GO:0060155) | 2.62792248 |
133 | lactate metabolic process (GO:0006089) | 2.60603399 |
134 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.60277871 |
135 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.59056675 |
136 | fibrinolysis (GO:0042730) | 2.58896775 |
137 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.58544883 |
138 | L-methionine salvage (GO:0071267) | 2.58055554 |
139 | L-methionine biosynthetic process (GO:0071265) | 2.58055554 |
140 | amino acid salvage (GO:0043102) | 2.58055554 |
141 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.57578742 |
142 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.57578742 |
143 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.57578742 |
144 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.56414068 |
145 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.56414068 |
146 | protein deneddylation (GO:0000338) | 2.55852897 |
147 | negative regulation of ligase activity (GO:0051352) | 2.53502062 |
148 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.53502062 |
149 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.52008473 |
150 | regulation of lipoprotein metabolic process (GO:0050746) | 2.49942733 |
151 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.49561972 |
152 | hydrogen peroxide catabolic process (GO:0042744) | 2.49107686 |
153 | response to hydroperoxide (GO:0033194) | 2.48948372 |
154 | membrane budding (GO:0006900) | 2.48920288 |
155 | CENP-A containing nucleosome assembly (GO:0034080) | 2.48586171 |
156 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48019758 |
157 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48019758 |
158 | pyrimidine nucleoside salvage (GO:0043097) | 2.45734356 |
159 | pyrimidine-containing compound salvage (GO:0008655) | 2.45734356 |
160 | glycerol ether metabolic process (GO:0006662) | 2.45276307 |
161 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.44623328 |
162 | glutathione metabolic process (GO:0006749) | 2.43294006 |
163 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.42700639 |
164 | branched-chain amino acid catabolic process (GO:0009083) | 2.42332544 |
165 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.41880240 |
166 | establishment of integrated proviral latency (GO:0075713) | 2.39393734 |
167 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.38379164 |
168 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.37413171 |
169 | purine-containing compound salvage (GO:0043101) | 2.37071729 |
170 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.36201846 |
171 | chromatin remodeling at centromere (GO:0031055) | 2.35446860 |
172 | negative regulation of coagulation (GO:0050819) | 2.34711456 |
173 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.34463692 |
174 | epoxygenase P450 pathway (GO:0019373) | 2.33913982 |
175 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.33220987 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.94477542 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.34423897 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97029988 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.78302353 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70371648 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.24340581 |
7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99500500 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.83480170 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.78142956 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.75832970 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.66856337 |
12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.35479516 |
13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.32399558 |
14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.30219378 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.21392330 |
16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.16355482 |
17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.12754506 |
18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03935958 |
19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01452430 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00809770 |
21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00338847 |
22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98241502 |
23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.98125315 |
24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.88296137 |
25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.86804794 |
26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82914091 |
27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82718241 |
28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.81136955 |
29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80319150 |
30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.73195376 |
31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71447390 |
32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.70331906 |
33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.65632543 |
34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.65218198 |
35 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62036077 |
36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60887732 |
37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53283528 |
38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.50446519 |
39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.49554129 |
40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44905820 |
41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44181952 |
42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44075628 |
43 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41554032 |
44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40937214 |
45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40120476 |
46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.39875467 |
47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.39860854 |
48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35322719 |
49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34771572 |
50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33540192 |
51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31720004 |
52 | AR_20517297_ChIP-Seq_VCAP_Human | 1.30497758 |
53 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30232784 |
54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29605811 |
55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29574418 |
56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29409680 |
57 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29278721 |
58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28834645 |
59 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25941621 |
60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25828978 |
61 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25158160 |
62 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24260987 |
63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23568845 |
64 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.22432425 |
65 | MYC_22102868_ChIP-Seq_BL_Human | 1.21010549 |
66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20450131 |
67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20121510 |
68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16943585 |
69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15465435 |
70 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.14341046 |
71 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14054023 |
72 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12679852 |
73 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.12552568 |
74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.11511505 |
75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11084292 |
76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10835139 |
77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09658849 |
78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09599446 |
79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09255921 |
80 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08971952 |
81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08909937 |
82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08898532 |
83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08185157 |
84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07873000 |
85 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07455672 |
86 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07428125 |
87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07200774 |
88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07200774 |
89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06580488 |
90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06475763 |
91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06303045 |
92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05884248 |
93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05884248 |
94 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05596338 |
95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05330866 |
96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05201803 |
97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04827190 |
98 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04732808 |
99 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04394809 |
100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04355780 |
101 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03256827 |
102 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03150247 |
103 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03150247 |
104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02715023 |
105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02498538 |
106 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01902339 |
107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01797490 |
108 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01711730 |
109 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01643145 |
110 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00660159 |
111 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00574910 |
112 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.99740406 |
113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98638667 |
114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97741763 |
115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97613789 |
116 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97238251 |
117 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97101309 |
118 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96419359 |
119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96010377 |
120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95398631 |
121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95283516 |
122 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95084855 |
123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94684954 |
124 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.94392435 |
125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94005449 |
126 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93701621 |
127 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.93116541 |
128 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93004639 |
129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92852139 |
130 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.90941509 |
131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90754665 |
132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90232790 |
133 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89801676 |
134 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89421576 |
135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89111536 |
136 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.88461064 |
137 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.88057448 |
138 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87084499 |
139 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87023727 |
140 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86980752 |
141 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86980752 |
142 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86586626 |
143 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83613308 |
144 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83438594 |
145 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81061861 |
146 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81034514 |
147 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80890062 |
148 | MYB_26560356_Chip-Seq_TH1_Human | 0.80779250 |
149 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80306830 |
150 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.79584462 |
151 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.77105404 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.07849155 |
2 | MP0005360_urolithiasis | 5.90969564 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.51912294 |
4 | MP0005365_abnormal_bile_salt | 4.38313832 |
5 | MP0003806_abnormal_nucleotide_metabolis | 4.35922690 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.53341125 |
7 | MP0000372_irregular_coat_pigmentation | 3.43053081 |
8 | MP0010234_abnormal_vibrissa_follicle | 3.13512954 |
9 | MP0009840_abnormal_foam_cell | 2.73695002 |
10 | MP0003252_abnormal_bile_duct | 2.71078543 |
11 | MP0003136_yellow_coat_color | 2.58989732 |
12 | MP0009780_abnormal_chondrocyte_physiolo | 2.57224598 |
13 | MP0010329_abnormal_lipoprotein_level | 2.44174584 |
14 | MP0001666_abnormal_nutrient_absorption | 2.17926572 |
15 | MP0005083_abnormal_biliary_tract | 2.17780352 |
16 | MP0005332_abnormal_amino_acid | 2.14603222 |
17 | MP0003186_abnormal_redox_activity | 1.93235065 |
18 | MP0003693_abnormal_embryo_hatching | 1.89755990 |
19 | MP0003950_abnormal_plasma_membrane | 1.88366781 |
20 | MP0003191_abnormal_cellular_cholesterol | 1.81940633 |
21 | MP0008004_abnormal_stomach_pH | 1.79968659 |
22 | MP0000609_abnormal_liver_physiology | 1.79863330 |
23 | MP0004019_abnormal_vitamin_homeostasis | 1.79625155 |
24 | MP0010678_abnormal_skin_adnexa | 1.75266522 |
25 | MP0001764_abnormal_homeostasis | 1.72524695 |
26 | MP0001661_extended_life_span | 1.65711193 |
27 | MP0002138_abnormal_hepatobiliary_system | 1.63665591 |
28 | MP0002090_abnormal_vision | 1.63349689 |
29 | MP0003195_calcinosis | 1.62289759 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.60764243 |
31 | MP0009697_abnormal_copulation | 1.49662549 |
32 | MP0005379_endocrine/exocrine_gland_phen | 1.45094180 |
33 | MP0001835_abnormal_antigen_presentation | 1.41407983 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.41066618 |
35 | MP0004957_abnormal_blastocyst_morpholog | 1.38800657 |
36 | MP0002938_white_spotting | 1.37269793 |
37 | MP0010094_abnormal_chromosome_stability | 1.35340917 |
38 | MP0009643_abnormal_urine_homeostasis | 1.31390481 |
39 | MP0002118_abnormal_lipid_homeostasis | 1.29504823 |
40 | MP0003868_abnormal_feces_composition | 1.28677481 |
41 | MP0003436_decreased_susceptibility_to | 1.28580728 |
42 | MP0004272_abnormal_basement_membrane | 1.28317868 |
43 | MP0002877_abnormal_melanocyte_morpholog | 1.27471002 |
44 | MP0010386_abnormal_urinary_bladder | 1.27031851 |
45 | MP0002163_abnormal_gland_morphology | 1.26257070 |
46 | MP0000598_abnormal_liver_morphology | 1.25363403 |
47 | MP0003111_abnormal_nucleus_morphology | 1.23532046 |
48 | MP0003941_abnormal_skin_development | 1.23035584 |
49 | MP0005451_abnormal_body_composition | 1.21265130 |
50 | MP0002132_abnormal_respiratory_system | 1.19238140 |
51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18754278 |
52 | MP0008469_abnormal_protein_level | 1.18329459 |
53 | MP0003011_delayed_dark_adaptation | 1.18108988 |
54 | MP0002396_abnormal_hematopoietic_system | 1.16882445 |
55 | MP0003077_abnormal_cell_cycle | 1.14343938 |
56 | MP0008872_abnormal_physiological_respon | 1.14288568 |
57 | MP0009785_altered_susceptibility_to | 1.14280716 |
58 | MP0000343_altered_response_to | 1.13232925 |
59 | MP0008775_abnormal_heart_ventricle | 1.11169049 |
60 | MP0009763_increased_sensitivity_to | 1.09958221 |
61 | MP0001756_abnormal_urination | 1.09644444 |
62 | MP0002876_abnormal_thyroid_physiology | 1.08155216 |
63 | MP0005395_other_phenotype | 1.07996556 |
64 | MP0005464_abnormal_platelet_physiology | 1.05302584 |
65 | MP0001853_heart_inflammation | 1.04053539 |
66 | MP0008932_abnormal_embryonic_tissue | 1.02662327 |
67 | MP0005408_hypopigmentation | 1.01652510 |
68 | MP0006036_abnormal_mitochondrial_physio | 1.01123738 |
69 | MP0005025_abnormal_response_to | 1.00558371 |
70 | MP0003566_abnormal_cell_adhesion | 1.00405352 |
71 | MP0000685_abnormal_immune_system | 1.00187148 |
72 | MP0001800_abnormal_humoral_immune | 1.00111778 |
73 | MP0000490_abnormal_crypts_of | 0.99731468 |
74 | MP0009764_decreased_sensitivity_to | 0.99184033 |
75 | MP0008057_abnormal_DNA_replication | 0.98926727 |
76 | MP0003638_abnormal_response/metabolism_ | 0.97695474 |
77 | MP0000358_abnormal_cell_content/ | 0.97664872 |
78 | MP0003724_increased_susceptibility_to | 0.97261203 |
79 | MP0010030_abnormal_orbit_morphology | 0.96292460 |
80 | MP0005248_abnormal_Harderian_gland | 0.93786128 |
81 | MP0003718_maternal_effect | 0.93492347 |
82 | MP0005165_increased_susceptibility_to | 0.93219268 |
83 | MP0000230_abnormal_systemic_arterial | 0.93057394 |
84 | MP0005636_abnormal_mineral_homeostasis | 0.91731540 |
85 | MP0003705_abnormal_hypodermis_morpholog | 0.90655552 |
86 | MP0009333_abnormal_splenocyte_physiolog | 0.88755612 |
87 | MP0010155_abnormal_intestine_physiology | 0.88451373 |
88 | MP0001845_abnormal_inflammatory_respons | 0.87548876 |
89 | MP0000689_abnormal_spleen_morphology | 0.87411425 |
90 | MP0000647_abnormal_sebaceous_gland | 0.87318230 |
91 | MP0000015_abnormal_ear_pigmentation | 0.87282966 |
92 | MP0000383_abnormal_hair_follicle | 0.86890830 |
93 | MP0002419_abnormal_innate_immunity | 0.86235467 |
94 | MP0002295_abnormal_pulmonary_circulatio | 0.85497365 |
95 | MP0008058_abnormal_DNA_repair | 0.85345410 |
96 | MP0005075_abnormal_melanosome_morpholog | 0.85208305 |
97 | MP0006054_spinal_hemorrhage | 0.84166418 |
98 | MP0010352_gastrointestinal_tract_polyps | 0.84031718 |
99 | MP0004264_abnormal_extraembryonic_tissu | 0.83766571 |
100 | MP0005410_abnormal_fertilization | 0.83675405 |
101 | MP0005220_abnormal_exocrine_pancreas | 0.83009928 |
102 | MP0009053_abnormal_anal_canal | 0.81405879 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.79996993 |
104 | MP0002452_abnormal_antigen_presenting | 0.79899047 |
105 | MP0005501_abnormal_skin_physiology | 0.79805254 |
106 | MP0003763_abnormal_thymus_physiology | 0.79502408 |
107 | MP0002722_abnormal_immune_system | 0.79452771 |
108 | MP0005671_abnormal_response_to | 0.78238810 |
109 | MP0006082_CNS_inflammation | 0.77921484 |
110 | MP0002723_abnormal_immune_serum | 0.77117333 |
111 | MP0004147_increased_porphyrin_level | 0.76305551 |
112 | MP0005376_homeostasis/metabolism_phenot | 0.76080485 |
113 | MP0008007_abnormal_cellular_replicative | 0.74431193 |
114 | MP0005084_abnormal_gallbladder_morpholo | 0.74275379 |
115 | MP0002398_abnormal_bone_marrow | 0.74081826 |
116 | MP0002019_abnormal_tumor_incidence | 0.73942641 |
117 | MP0002136_abnormal_kidney_physiology | 0.73081809 |
118 | MP0002429_abnormal_blood_cell | 0.72715542 |
119 | MP0005266_abnormal_metabolism | 0.72481105 |
120 | MP0005000_abnormal_immune_tolerance | 0.71892432 |
121 | MP0001545_abnormal_hematopoietic_system | 0.71626632 |
122 | MP0005397_hematopoietic_system_phenotyp | 0.71626632 |
123 | MP0009642_abnormal_blood_homeostasis | 0.71033944 |
124 | MP0001873_stomach_inflammation | 0.70488262 |
125 | MP0000716_abnormal_immune_system | 0.69900523 |
126 | MP0009379_abnormal_foot_pigmentation | 0.69619945 |
127 | MP0005058_abnormal_lysosome_morphology | 0.69610663 |
128 | MP0004947_skin_inflammation | 0.69518041 |
129 | MP0005023_abnormal_wound_healing | 0.68288242 |
130 | MP0001881_abnormal_mammary_gland | 0.68266704 |
131 | MP0002420_abnormal_adaptive_immunity | 0.67277749 |
132 | MP0005171_absent_coat_pigmentation | 0.66862549 |
133 | MP0001819_abnormal_immune_cell | 0.66591126 |
134 | MP0005387_immune_system_phenotype | 0.65794460 |
135 | MP0001790_abnormal_immune_system | 0.65794460 |
136 | MP0005647_abnormal_sex_gland | 0.65708492 |
137 | MP0000858_altered_metastatic_potential | 0.65549691 |
138 | MP0002254_reproductive_system_inflammat | 0.65210908 |
139 | MP0002148_abnormal_hypersensitivity_rea | 0.64952527 |
140 | MP0002166_altered_tumor_susceptibility | 0.64791290 |
141 | MP0008873_increased_physiological_sensi | 0.64551833 |
142 | MP0002837_dystrophic_cardiac_calcinosis | 0.64347555 |
143 | MP0002909_abnormal_adrenal_gland | 0.62472089 |
144 | MP0005197_abnormal_uvea_morphology | 0.58559901 |
145 | MP0000427_abnormal_hair_cycle | 0.58130790 |
146 | MP0001851_eye_inflammation | 0.57661049 |
147 | MP0003786_premature_aging | 0.57250178 |
148 | MP0005174_abnormal_tail_pigmentation | 0.56949694 |
149 | MP0006072_abnormal_retinal_apoptosis | 0.55978787 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.55340672 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.54159117 |
3 | Petechiae (HP:0000967) | 5.54099203 |
4 | Intrahepatic cholestasis (HP:0001406) | 5.48834042 |
5 | Hypobetalipoproteinemia (HP:0003563) | 5.31922515 |
6 | Deep venous thrombosis (HP:0002625) | 4.79343986 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 4.52438998 |
8 | Xanthomatosis (HP:0000991) | 4.43719747 |
9 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.14788387 |
10 | Hyperammonemia (HP:0001987) | 3.83749327 |
11 | Hepatocellular necrosis (HP:0001404) | 3.63112651 |
12 | Hyperglycinemia (HP:0002154) | 3.62346969 |
13 | Hypolipoproteinemia (HP:0010981) | 3.59521676 |
14 | Hyperlipoproteinemia (HP:0010980) | 3.59085836 |
15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.53629553 |
16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.53612218 |
17 | Joint hemorrhage (HP:0005261) | 3.52740442 |
18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.51063424 |
19 | Abnormality of methionine metabolism (HP:0010901) | 3.50201974 |
20 | Hyperglycinuria (HP:0003108) | 3.41099873 |
21 | Fat malabsorption (HP:0002630) | 3.40353449 |
22 | Abnormality of glycine metabolism (HP:0010895) | 3.32377224 |
23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.32377224 |
24 | Hypoglycemic coma (HP:0001325) | 3.29721940 |
25 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28206269 |
26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.25575476 |
27 | Complement deficiency (HP:0004431) | 3.24093947 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.22920136 |
29 | Acute encephalopathy (HP:0006846) | 3.09358908 |
30 | Purpura (HP:0000979) | 3.05541921 |
31 | Increased CSF lactate (HP:0002490) | 3.05541856 |
32 | Hyperbilirubinemia (HP:0002904) | 3.04714277 |
33 | Mitochondrial inheritance (HP:0001427) | 3.02122261 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.01035504 |
35 | Epidermoid cyst (HP:0200040) | 2.99772646 |
36 | Ketosis (HP:0001946) | 2.96224735 |
37 | Dyschromatopsia (HP:0007641) | 2.93723175 |
38 | Acute necrotizing encephalopathy (HP:0006965) | 2.91821409 |
39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87782274 |
40 | Abnormality of nucleobase metabolism (HP:0010932) | 2.83157869 |
41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82823897 |
42 | Abnormality of serum amino acid levels (HP:0003112) | 2.82543970 |
43 | Abnormality of the anterior horn cell (HP:0006802) | 2.82260906 |
44 | Degeneration of anterior horn cells (HP:0002398) | 2.82260906 |
45 | Prolonged bleeding time (HP:0003010) | 2.71851692 |
46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.70980185 |
47 | Steatorrhea (HP:0002570) | 2.70345248 |
48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.69448452 |
49 | Hypercholesterolemia (HP:0003124) | 2.65174458 |
50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64972246 |
51 | Dicarboxylic aciduria (HP:0003215) | 2.64972246 |
52 | Hypoalphalipoproteinemia (HP:0003233) | 2.63957014 |
53 | Abnormality of complement system (HP:0005339) | 2.62539234 |
54 | Progressive macrocephaly (HP:0004481) | 2.62254805 |
55 | CNS demyelination (HP:0007305) | 2.57720058 |
56 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.57071109 |
57 | Hypoplasia of the fovea (HP:0007750) | 2.57071109 |
58 | Hepatocellular carcinoma (HP:0001402) | 2.56192560 |
59 | Abnormal pupillary function (HP:0007686) | 2.50440609 |
60 | Generalized aminoaciduria (HP:0002909) | 2.48061029 |
61 | Renal Fanconi syndrome (HP:0001994) | 2.47777060 |
62 | Lethargy (HP:0001254) | 2.41995641 |
63 | Nausea (HP:0002018) | 2.41772064 |
64 | Spastic diplegia (HP:0001264) | 2.41195085 |
65 | Reduced antithrombin III activity (HP:0001976) | 2.37052870 |
66 | Delayed CNS myelination (HP:0002188) | 2.37020010 |
67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34003271 |
68 | Cardiovascular calcification (HP:0011915) | 2.33115683 |
69 | Hydroxyprolinuria (HP:0003080) | 2.32556747 |
70 | Abnormality of proline metabolism (HP:0010907) | 2.32556747 |
71 | Lactic acidosis (HP:0003128) | 2.30691817 |
72 | Respiratory failure (HP:0002878) | 2.29945669 |
73 | Hypokinesia (HP:0002375) | 2.29841460 |
74 | Increased hepatocellular lipid droplets (HP:0006565) | 2.29831030 |
75 | Metabolic acidosis (HP:0001942) | 2.29330589 |
76 | Hypophosphatemic rickets (HP:0004912) | 2.28513439 |
77 | Acanthocytosis (HP:0001927) | 2.28102836 |
78 | Sparse eyelashes (HP:0000653) | 2.27256633 |
79 | Hypochromic microcytic anemia (HP:0004840) | 2.26012496 |
80 | Posterior subcapsular cataract (HP:0007787) | 2.24473024 |
81 | Reticulocytopenia (HP:0001896) | 2.23039163 |
82 | Increased serum lactate (HP:0002151) | 2.18051934 |
83 | Abnormality of purine metabolism (HP:0004352) | 2.17342610 |
84 | Increased serum pyruvate (HP:0003542) | 2.17100374 |
85 | Myocardial infarction (HP:0001658) | 2.16656659 |
86 | Vacuolated lymphocytes (HP:0001922) | 2.15749710 |
87 | Cerebral edema (HP:0002181) | 2.15125034 |
88 | Abnormality of iron homeostasis (HP:0011031) | 2.15056387 |
89 | Impaired platelet aggregation (HP:0003540) | 2.13225083 |
90 | Abnormal platelet function (HP:0011869) | 2.13225083 |
91 | Abnormality of the fovea (HP:0000493) | 2.12142289 |
92 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.11791904 |
93 | Symptomatic seizures (HP:0011145) | 2.11539531 |
94 | Gingival bleeding (HP:0000225) | 2.11040549 |
95 | Proximal tubulopathy (HP:0000114) | 2.10395683 |
96 | Abnormality of glycolysis (HP:0004366) | 2.10125544 |
97 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08128495 |
98 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08128495 |
99 | Megaloblastic anemia (HP:0001889) | 2.07755483 |
100 | Abnormal auditory evoked potentials (HP:0006958) | 2.06782379 |
101 | Congenital sensorineural hearing impairment (HP:0008527) | 2.04889517 |
102 | Opisthotonus (HP:0002179) | 2.04485489 |
103 | Abnormality of alanine metabolism (HP:0010916) | 2.04416151 |
104 | Hyperalaninemia (HP:0003348) | 2.04416151 |
105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04416151 |
106 | Systemic lupus erythematosus (HP:0002725) | 2.03188728 |
107 | Glycosuria (HP:0003076) | 2.02580452 |
108 | Abnormality of urine glucose concentration (HP:0011016) | 2.02580452 |
109 | Macrocytic anemia (HP:0001972) | 2.02513857 |
110 | Oral leukoplakia (HP:0002745) | 2.01681915 |
111 | Type I transferrin isoform profile (HP:0003642) | 2.00891056 |
112 | Abnormality of vitamin B metabolism (HP:0004340) | 2.00852701 |
113 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99839241 |
114 | Biliary tract neoplasm (HP:0100574) | 1.98377964 |
115 | Poikilocytosis (HP:0004447) | 1.97945104 |
116 | Renal cortical cysts (HP:0000803) | 1.96622666 |
117 | Hypothermia (HP:0002045) | 1.95664317 |
118 | Pancreatitis (HP:0001733) | 1.94684478 |
119 | Increased serum ferritin (HP:0003281) | 1.93315540 |
120 | Hyperphosphaturia (HP:0003109) | 1.93155412 |
121 | Hepatic necrosis (HP:0002605) | 1.92906142 |
122 | Esophageal varix (HP:0002040) | 1.92893455 |
123 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.92536570 |
124 | Albinism (HP:0001022) | 1.92432439 |
125 | Patchy hypopigmentation of hair (HP:0011365) | 1.91694325 |
126 | Thrombocytosis (HP:0001894) | 1.91455489 |
127 | Malnutrition (HP:0004395) | 1.91024723 |
128 | Thrombophlebitis (HP:0004418) | 1.90481325 |
129 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.89749251 |
130 | Vascular calcification (HP:0004934) | 1.89457063 |
131 | Abnormal number of erythroid precursors (HP:0012131) | 1.88862600 |
132 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.88346528 |
133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87924722 |
134 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.87836424 |
135 | Abnormal hemoglobin (HP:0011902) | 1.87515817 |
136 | Elevated hepatic transaminases (HP:0002910) | 1.86709675 |
137 | Mitral stenosis (HP:0001718) | 1.85572999 |
138 | Spontaneous abortion (HP:0005268) | 1.83906683 |
139 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83538018 |
140 | Abnormality of reticulocytes (HP:0004312) | 1.82575718 |
141 | Multiple enchondromatosis (HP:0005701) | 1.82498995 |
142 | Menorrhagia (HP:0000132) | 1.82287378 |
143 | Vomiting (HP:0002013) | 1.82006006 |
144 | Irritability (HP:0000737) | 1.81331057 |
145 | Abnormal cartilage morphology (HP:0002763) | 1.79961807 |
146 | Ketoacidosis (HP:0001993) | 1.79960450 |
147 | Abnormal platelet volume (HP:0011876) | 1.79684625 |
148 | Increased mean platelet volume (HP:0011877) | 1.79289016 |
149 | Hypochromic anemia (HP:0001931) | 1.79043409 |
150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78623333 |
151 | Glomerulonephritis (HP:0000099) | 1.76497800 |
152 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.74730678 |
153 | Hypoglycemic seizures (HP:0002173) | 1.73416947 |
154 | Late onset (HP:0003584) | 1.72637760 |
155 | Epistaxis (HP:0000421) | 1.71348712 |
156 | Microcytic anemia (HP:0001935) | 1.70022435 |
157 | Brushfield spots (HP:0001088) | 1.64454352 |
158 | Nonimmune hydrops fetalis (HP:0001790) | 1.64013572 |
159 | Autoimmune thrombocytopenia (HP:0001973) | 1.62322093 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 3.76668936 |
2 | EIF2AK1 | 2.96685408 |
3 | MAP3K12 | 2.96456743 |
4 | PDK2 | 2.72163322 |
5 | NME2 | 2.66378934 |
6 | TRIM28 | 2.54358150 |
7 | MYLK | 2.43768287 |
8 | BMPR1B | 2.35563438 |
9 | BUB1 | 2.32285076 |
10 | ERN1 | 2.29153773 |
11 | PBK | 2.25971789 |
12 | MAP4K1 | 2.21599567 |
13 | WEE1 | 2.10645418 |
14 | NUAK1 | 2.04962209 |
15 | VRK2 | 2.04856030 |
16 | FLT3 | 1.95512686 |
17 | STK16 | 1.91433798 |
18 | EIF2AK3 | 1.88092479 |
19 | TLK1 | 1.85704011 |
20 | TESK2 | 1.84528402 |
21 | STK24 | 1.83094561 |
22 | CDC7 | 1.80507142 |
23 | FGFR4 | 1.79629272 |
24 | RPS6KA4 | 1.78210681 |
25 | ACVR1B | 1.69230796 |
26 | BLK | 1.67751205 |
27 | TYK2 | 1.62054333 |
28 | KDR | 1.55953896 |
29 | TNIK | 1.52512125 |
30 | PLK2 | 1.48162646 |
31 | STK10 | 1.45800441 |
32 | MAP3K10 | 1.43507208 |
33 | SIK1 | 1.41849206 |
34 | NEK2 | 1.39546494 |
35 | TAOK3 | 1.39161659 |
36 | IRAK3 | 1.39111283 |
37 | PIM2 | 1.38334631 |
38 | PKN2 | 1.36786061 |
39 | PLK3 | 1.34084092 |
40 | TBK1 | 1.33658851 |
41 | GRK6 | 1.32395222 |
42 | BCR | 1.31582976 |
43 | MAP4K2 | 1.26074269 |
44 | ERBB3 | 1.25538965 |
45 | PLK4 | 1.25193277 |
46 | TTK | 1.23993145 |
47 | MAPKAPK3 | 1.22469866 |
48 | STK4 | 1.22194387 |
49 | CDK4 | 1.20215823 |
50 | MAP3K11 | 1.19216923 |
51 | BTK | 1.16970600 |
52 | PIM1 | 1.16805625 |
53 | CSF1R | 1.15546538 |
54 | RPS6KB2 | 1.14964407 |
55 | MAP3K14 | 1.13964346 |
56 | MAP2K3 | 1.12272544 |
57 | MAP3K8 | 1.12134471 |
58 | TEC | 1.10912391 |
59 | ILK | 1.10589897 |
60 | DYRK3 | 1.09760146 |
61 | CDK7 | 1.09302237 |
62 | BRSK2 | 1.09256514 |
63 | MAPK11 | 1.08016097 |
64 | AURKB | 1.07602027 |
65 | MET | 1.07548601 |
66 | GRK1 | 1.07369204 |
67 | VRK1 | 1.04800570 |
68 | LRRK2 | 1.04405895 |
69 | KIT | 1.03899607 |
70 | ADRBK2 | 1.03677395 |
71 | EPHA2 | 1.03312538 |
72 | PIK3CG | 1.03265531 |
73 | MAP3K3 | 1.02002992 |
74 | NEK9 | 0.99898808 |
75 | SRPK1 | 0.97538776 |
76 | ZAP70 | 0.96683609 |
77 | NEK1 | 0.96150599 |
78 | MUSK | 0.96077553 |
79 | PLK1 | 0.95151101 |
80 | SIK3 | 0.94454648 |
81 | LMTK2 | 0.94234623 |
82 | IRAK4 | 0.93003102 |
83 | JAK3 | 0.91577135 |
84 | ATR | 0.91303346 |
85 | TXK | 0.90834593 |
86 | BMPR2 | 0.89993217 |
87 | CSNK1G1 | 0.87916049 |
88 | IKBKB | 0.86306343 |
89 | CSNK1G3 | 0.85088505 |
90 | FER | 0.84582795 |
91 | BMX | 0.83336065 |
92 | SCYL2 | 0.83087643 |
93 | DAPK1 | 0.81551635 |
94 | IKBKE | 0.80849524 |
95 | LIMK1 | 0.80747155 |
96 | FRK | 0.79002753 |
97 | ABL2 | 0.78947322 |
98 | PTK2B | 0.77679792 |
99 | CDK6 | 0.77481555 |
100 | TAF1 | 0.74269402 |
101 | EIF2AK2 | 0.72408555 |
102 | PAK4 | 0.72226298 |
103 | EEF2K | 0.70745569 |
104 | PASK | 0.68736056 |
105 | LYN | 0.67364228 |
106 | DAPK3 | 0.67101770 |
107 | PTK6 | 0.66692372 |
108 | ITK | 0.64933678 |
109 | ARAF | 0.64869705 |
110 | TGFBR2 | 0.64323051 |
111 | OXSR1 | 0.64124785 |
112 | GRK5 | 0.63543676 |
113 | MKNK1 | 0.63145202 |
114 | STK39 | 0.62823503 |
115 | CSK | 0.62357476 |
116 | MST1R | 0.61967900 |
117 | ZAK | 0.60667327 |
118 | ERBB4 | 0.60107690 |
119 | TGFBR1 | 0.60053339 |
120 | AURKA | 0.59412790 |
121 | NLK | 0.59230216 |
122 | TRIB3 | 0.58411510 |
123 | PAK1 | 0.57873423 |
124 | TAOK2 | 0.57345238 |
125 | SYK | 0.56419630 |
126 | CHUK | 0.53789705 |
127 | MST4 | 0.51944764 |
128 | MELK | 0.51740697 |
129 | TESK1 | 0.51557419 |
130 | CDK8 | 0.51074350 |
131 | CSNK1G2 | 0.50585457 |
132 | JAK2 | 0.49152683 |
133 | CSNK2A1 | 0.48996863 |
134 | BRSK1 | 0.47637266 |
135 | WNK3 | 0.47314659 |
136 | CDK12 | 0.46768132 |
137 | RPS6KA5 | 0.44589469 |
138 | STK38L | 0.44441008 |
139 | CSNK1A1L | 0.43816083 |
140 | CLK1 | 0.43269241 |
141 | CSNK2A2 | 0.42710964 |
142 | PRKCE | 0.42638251 |
143 | LCK | 0.42110686 |
144 | MAP2K2 | 0.41562341 |
145 | MAP2K6 | 0.40848797 |
146 | STK3 | 0.40169234 |
147 | MKNK2 | 0.37658572 |
148 | TRPM7 | 0.37578112 |
149 | ADRBK1 | 0.36048756 |
150 | MINK1 | 0.32365244 |
151 | ROCK1 | 0.31439993 |
152 | IGF1R | 0.27138625 |
153 | MOS | 0.27030767 |
154 | PRKCI | 0.26220580 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31654808 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01930475 |
3 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31673775 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30153563 |
5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.25996177 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20308634 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13628503 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10229155 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08861425 |
10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.08477290 |
11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.04469759 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02870773 |
13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.93092412 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92788611 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.90822397 |
16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85941557 |
17 | DNA replication_Homo sapiens_hsa03030 | 1.84839671 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82658619 |
19 | Peroxisome_Homo sapiens_hsa04146 | 1.78937665 |
20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74357903 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73998368 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70494400 |
23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.69021636 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60161558 |
25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.57043214 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56478293 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54328463 |
28 | Ribosome_Homo sapiens_hsa03010 | 1.50873023 |
29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50806324 |
30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47012898 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46708026 |
32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45715662 |
33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44237352 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43737128 |
35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42952731 |
36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42602139 |
37 | Mismatch repair_Homo sapiens_hsa03430 | 1.40862802 |
38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35962008 |
39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.34628352 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33674835 |
41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33255921 |
42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28878645 |
43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28677608 |
44 | Proteasome_Homo sapiens_hsa03050 | 1.26180110 |
45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25489254 |
46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23480671 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23223952 |
48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22974556 |
49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22188986 |
50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17531552 |
51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16891836 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13405643 |
53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12819486 |
54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10404617 |
55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09490296 |
56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08352389 |
57 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07618812 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07013779 |
59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06811988 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05620462 |
61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04892295 |
62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.03904183 |
63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03138236 |
64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99979288 |
65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96976691 |
66 | Base excision repair_Homo sapiens_hsa03410 | 0.96498031 |
67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96451798 |
68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94895780 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92288855 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92246034 |
71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87204153 |
72 | ABC transporters_Homo sapiens_hsa02010 | 0.86231041 |
73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85237532 |
74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82629352 |
75 | Homologous recombination_Homo sapiens_hsa03440 | 0.81767877 |
76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80426917 |
77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79664233 |
78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77405674 |
79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77227919 |
80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76399134 |
81 | Bile secretion_Homo sapiens_hsa04976 | 0.75768772 |
82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73894771 |
83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72216427 |
84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70463008 |
85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65907303 |
86 | Spliceosome_Homo sapiens_hsa03040 | 0.64781455 |
87 | Lysine degradation_Homo sapiens_hsa00310 | 0.64744773 |
88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64581107 |
89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63935985 |
90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62470112 |
91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61963217 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.61059799 |
93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.61036419 |
94 | RNA polymerase_Homo sapiens_hsa03020 | 0.59389298 |
95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58260343 |
96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58068316 |
97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56972267 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56166592 |
99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56019557 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53619008 |
101 | RNA transport_Homo sapiens_hsa03013 | 0.48010108 |
102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.45571771 |
103 | Cell cycle_Homo sapiens_hsa04110 | 0.40458940 |
104 | Legionellosis_Homo sapiens_hsa05134 | 0.39954015 |
105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37506754 |
106 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36840355 |
107 | Protein export_Homo sapiens_hsa03060 | 0.36581310 |
108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35452596 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34734666 |
110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32661075 |
111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32362077 |
112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31873274 |
113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30462150 |
114 | Platelet activation_Homo sapiens_hsa04611 | 0.30443749 |
115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30427868 |
116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30178133 |
117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25724756 |
118 | RNA degradation_Homo sapiens_hsa03018 | 0.23500026 |
119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.23310752 |
120 | Purine metabolism_Homo sapiens_hsa00230 | 0.22861218 |
121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22641417 |
122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20696313 |
123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19720102 |